BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37632533)

  • 1. Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma.
    Kir G; Cecikoglu GE; Topal CS; Sorkun MH; Culpan M; Suceken FY; Karaca H; Yildirim A
    Virchows Arch; 2023 Nov; 483(5):621-634. PubMed ID: 37632533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-Grade Urothelial Carcinoma: Insights Into Clinical Behavior and Prognostic Implications Compared to Pure Low-Grade and High-Grade Urothelial Carcinomas.
    Khalatbari F; Moafi-Madani M; Amin A
    Arch Pathol Lab Med; 2024 Mar; ():. PubMed ID: 38432312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
    Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
    Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.
    Mai KT; Flood TA; Williams P; Kos Z; Belanger EC
    Virchows Arch; 2013 Oct; 463(4):575-81. PubMed ID: 23913166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
    Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
    Syed M; Mushtaq S; Loya A; Hassan U; Mir K; Hussain M; Hameed M; Sheikh UN
    Ann Diagn Pathol; 2023 Apr; 63():152079. PubMed ID: 36549142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
    Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of texture analysis in differentiation of urothelial carcinoma based on multiphase computed tomography images.
    Wang Z; He Y; Wang N; Zhang T; Wu H; Jiang X; Mo L
    Medicine (Baltimore); 2020 May; 99(18):e20093. PubMed ID: 32358396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor.
    Liu Z; Wei S; Tang J
    Am J Clin Oncol; 2023 Sep; 46(9):409-413. PubMed ID: 37370208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder.
    Krüger S; Thorns C; Böhle A; Feller AC
    Int Urol Nephrol; 2003; 35(2):169-73. PubMed ID: 15072488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
    Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Navone R
    Am J Surg Pathol; 2001 Dec; 25(12):1528-33. PubMed ID: 11717543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Jones TD; Cheng L
    Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive papillary urothelial carcinoma with 'micropapillary' architecture: clinicopathological study of 18 patients emphasising clinical outcomes.
    Sangoi AR; Cox RM; Higgins JP; Quick CM; McKenney JK
    Histopathology; 2020 Nov; 77(5):728-733. PubMed ID: 32443178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
    Montoya-Cerrillo D; Briski LM; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2022 May; 30(3):260-264. PubMed ID: 34665053
    [No Abstract]   [Full Text] [Related]  

  • 20. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
    Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
    Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.